1. Gastro-Oesophageal Reflux Disease Pipeline by Stages

2. Gastro-Oesophageal Reflux Disease Pipeline by Drug Class

3. Gastro-Oesophageal Reflux Disease Pipeline by Company

4. Gastro-Oesophageal Reflux Disease Phase 3 Clinical Trial Insights

5. Gastro-Oesophageal Reflux Disease Phase 2 Clinical Trial Insights

6. Gastro-Oesophageal Reflux Disease Phase 1 Clinical Trial Insights

7. Gastro-Oesophageal Reflux Disease Preclinical Research Insights

8. Gastro-Oesophageal Reflux Disease Discovery Stage Insights

9. Appendix

10. Research Methodology

List of Tables
Table 1: Gastro-Oesophageal Reflux Disease Phase 3 Clinical Trials, 2017
Table 2: Gastro-Oesophageal Reflux Disease Phase 2 Clinical Trials, 2017
Table 3: Gastro-Oesophageal Reflux Disease Phase 1 Clinical Trials, 2017
Table 4: Gastro-Oesophageal Reflux Disease Preclinical Research, 2017
Table 5: Gastro-Oesophageal Reflux Disease Discovery Stage, 2017

List of Figures
Figure 1: Gastro-Oesophageal Reflux Disease Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Gastro-Oesophageal Reflux Disease Pipeline Molecules by Drug Class, 2017
Figure 3: Gastro-Oesophageal Reflux Disease Pipeline Molecules by Company, 2017
Figure 4: Gastro-Oesophageal Reflux Disease Phase 3 Clinical Trial Highlights, 2017
Figure 5: Gastro-Oesophageal Reflux Disease Phase 2 Clinical Trial Highlights, 2017
Figure 6: Gastro-Oesophageal Reflux Disease Phase 1 Clinical Trial Highlights, 2017
Figure 7: Gastro-Oesophageal Reflux Disease Preclinical Research Highlights, 2017
Figure 8: Gastro-Oesophageal Reflux Disease Discovery Stage Highlights, 2017